CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
IMPETUX is developing IMMUNOTRAP, a platform that uses optical tweezers to measure the interaction forces between immune cells and tumors. This technology aims to enhance personalized cancer treatments by identifying the most effective T cells for immunotherapy.
Cancers exhibit a large heterogeneity in terms of genetic mutations, so they respond differently to the same drugs.
This is why oncology is rapidly drifting towards treatments with new disrupting personalised inmuno-oncology therapies based on adoptive T-cell transfer (ACT).
These therapies aim at selecting the most efficient T cells against tumors and transferring them back to the patient.
This kind of Immunoassays are generally carried out with endpoint measurements like Surface Plasmon Resona…
IMPETUX OPTICS SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
